Alberto Laffranchi

1.0k total citations
22 papers, 829 citations indexed

About

Alberto Laffranchi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Alberto Laffranchi has authored 22 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Alberto Laffranchi's work include Cancer Treatment and Pharmacology (4 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Chemotherapy-induced cardiotoxicity and mitigation (4 papers). Alberto Laffranchi is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Chemotherapy-induced cardiotoxicity and mitigation (4 papers). Alberto Laffranchi collaborates with scholars based in Italy and United States. Alberto Laffranchi's co-authors include Flavio Villani, Luca Gianni, Emiliana Tarenzi, Elisabetta Munzone, Fabio Fulfaro, Carlo Spreafico, Augusto Caraceni, Giuseppe Capri, Cinzia Martini and G. Bonadonna and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Alberto Laffranchi

21 papers receiving 794 citations

Peers

Alberto Laffranchi
Rubina Qamar United States
H.T. Mouridsen Denmark
Sara Donati Italy
A. Vindevoghel Belgium
Luciano Canobbio Italy
Engracio P. Cortes United States
U. Klaassen Germany
Dimitrios Tryfonopoulos Greece
Jean-Luc Canon Belgium
M López Italy
Rubina Qamar United States
Alberto Laffranchi
Citations per year, relative to Alberto Laffranchi Alberto Laffranchi (= 1×) peers Rubina Qamar

Countries citing papers authored by Alberto Laffranchi

Since Specialization
Citations

This map shows the geographic impact of Alberto Laffranchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Laffranchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Laffranchi more than expected).

Fields of papers citing papers by Alberto Laffranchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto Laffranchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Laffranchi. The network helps show where Alberto Laffranchi may publish in the future.

Co-authorship network of co-authors of Alberto Laffranchi

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Laffranchi. A scholar is included among the top collaborators of Alberto Laffranchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Laffranchi. Alberto Laffranchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laffranchi, Alberto, Calogero Edoardo Cicero, Manuela Lualdi, et al.. (2018). Different pixel pitch and maximum luminance of medical grade displays may result in different evaluations of digital radiography images. La radiologia medica. 123(8). 586–592. 2 indexed citations
2.
3.
Laffranchi, Alberto, et al.. (2010). Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease.. PubMed. 30(10). 4381–7. 5 indexed citations
4.
Laffranchi, Alberto, et al.. (2009). Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.. PubMed. 29(2). 777–83. 12 indexed citations
5.
Villani, Flavio, A Catania, Alberto Laffranchi, et al.. (2003). Effect of an Intensive Chemotherapy Followed by Mediastinal Irradiation on Pulmonary and Cardiac Function in Advanced Hodgkin's Disease. Cancer Investigation. 21(2). 185–192. 5 indexed citations
6.
Villani, Fabrizio, Giovanna Viola, Chiara Vismara, et al.. (2002). Lung function and serum concentrations of different cytokines in patients submitted to radiotherapy and intermediate/high dose chemotherapy for Hodgkin's disease.. PubMed. 22(4). 2403–8. 7 indexed citations
7.
Villani, Fabrizio, et al.. (2000). Late Pulmonary Effects in Favorable Stage I and IIA Hodgkin’s Disease Treated With Radiotherapy Alone. American Journal of Clinical Oncology. 23(1). 18–21. 12 indexed citations
8.
Potepan, Paolo, Roberto Luksch, Gabriella Sozzi, et al.. (1999). Multifocal osteosarcoma as second tumor after childhood retinoblastoma. Skeletal Radiology. 28(7). 415–421. 13 indexed citations
9.
Villani, Flavio, V. Bonfante, Simonetta Viviani, et al.. (1998). Late pulmonary toxicity after treatment for Hodgkin's disease.. PubMed. 17(6D). 4739–42. 22 indexed citations
10.
Ferrari, Andrea, Alberto Laffranchi, Luciano Lombardi, et al.. (1997). Langerhans Cell Histiocytosis Arising After Hodgkin's Disease. Pediatric Hematology and Oncology. 14(6). 585–588. 5 indexed citations
11.
Zambetti, Milvia, Romano Demicheli, Giovanna Antonelli, et al.. (1997). Five-day infusion fluorouracil plus vinorelbine i.v. in metastatic pretreated breast cancer patients. Breast Cancer Research and Treatment. 44(3). 255–260. 22 indexed citations
12.
Potepan, Paolo, E. Meroni, I Spagnoli, et al.. (1996). Non-small-cell lung cancer: detection of mediastinal lymph node metastases by endoscopic ultrasound and CT. European Radiology. 6(1). 19–24. 12 indexed citations
13.
Bregni, Marco, Salvatore Siena, Massimo Di Nicola, et al.. (1996). Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.. Journal of Clinical Oncology. 14(2). 628–635. 26 indexed citations
14.
Potepan, Paolo, et al.. (1996). Langerhans Cell Histiocytosis Mimicking Malignancy: A Radiological Appraisal. Tumori Journal. 82(6). 603–609. 2 indexed citations
15.
Gianni, Luca, Elisabetta Munzone, Giuseppe Capri, et al.. (1995). Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study.. Journal of Clinical Oncology. 13(11). 2688–2699. 460 indexed citations
16.
Gianni, Luca, Elisabetta Munzone, Giuseppe Capri, et al.. (1995). Paclitaxel in Metastatic Breast Cancer:-a Trial of Two Doses by a 3-Hour Infusion in Patients With Dith Disease Recurrence After Prior Therapy With Anthracyclines. JNCI Journal of the National Cancer Institute. 87(15). 1169–1175. 129 indexed citations
17.
Zilembo, Nicoletta, Cristina Noberasco, Emilio Bajetta, et al.. (1995). Endocrinological and clinical evaluation of exemestane, a new steroidal aromatase inhibitor. British Journal of Cancer. 72(4). 1007–1012. 64 indexed citations
18.
Zilembo, Nicoletta, Emilio Bajetta, Cristina Noberasco, et al.. (1995). Formestane: an effective first-line endocrine treatment for advanced breast cancer. Journal of Cancer Research and Clinical Oncology. 121(6). 378–382. 3 indexed citations
19.
Potepan, Paolo, I Spagnoli, Gian Maria Danesini, et al.. (1994). [The radiodiagnosis of bone metastases from melanoma].. PubMed. 87(6). 741–6. 8 indexed citations
20.
Potepan, Paolo, et al.. (1992). Adrenal Gland Metastasis in Osteogenic Osteosarcoma. A Radiological Case Report. Tumori Journal. 78(6). 417–420. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rubina Qamar Breakdown of academic impact, for papers by H.T. Mouridsen Breakdown of academic impact, for papers by Sara Donati Breakdown of academic impact, for papers by A. Vindevoghel Breakdown of academic impact, for papers by Luciano Canobbio Breakdown of academic impact, for papers by Engracio P. Cortes Breakdown of academic impact, for papers by U. Klaassen Breakdown of academic impact, for papers by Dimitrios Tryfonopoulos Breakdown of academic impact, for papers by Jean-Luc Canon Breakdown of academic impact, for papers by M López
Rankless by CCL
2026